-
Thematic Analysis
NewFoodservices M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Foodservice Sector
-
Product Insights
Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Market Report Overview The transcatheter heart valve is an artificial heart valve made up of natural tissue surrounded by a flexible mesh frame known as stent. All the components are placed in a long narrow tube known as a catheter which is then inserted into a large blood vessel in the groin area or through a small incision in chest. The transcatheter mitral valve implantation (TMVI) pipeline market research report provides a comprehensive understanding...
-
Product Insights
NewAneurysm – Drugs In Development, 2024
Empower your strategies with our Aneurysm – Drugs In Development, 2024 report and make more profitable business decisions. An aneurysm is a weak or expanded bulge in the wall of an artery. The different types are abdominal aortic aneurysm (AAA), cerebral aneurysms, thoracic aortic aneurysm, and carotid, popliteal, mesenteric, and splenic aneurisms. Atherosclerosis, family history of aneurysm, high blood pressure, and injury to the aorta can be the causative parameters. Symptoms include lightheadedness; tachycardia; sudden, severe pain in the head, chest...
-
Product Insights
NewArteriosclerosis – Drugs In Development, 2024
Empower your strategies with our Arteriosclerosis – Drugs In Development, 2024 report and make more profitable business decisions. Arteriosclerosis refers to the thickening and hardening of arteries due to plaque buildup, limiting blood flow. Atherosclerosis, a common form, involves cholesterol and other substances accumulating in arterial walls, narrowing them. This condition heightens the risk of heart disease, stroke, and peripheral artery disease. Factors like high blood pressure, cholesterol, smoking, diabetes, and obesity contribute. Management involves lifestyle changes—such as a healthy diet...
-
Product Insights
NewAtherosclerosis – Drugs In Development, 2024
Empower your strategies with our Atherosclerosis – Drugs In Development, 2024 report and make more profitable business decisions. Atherosclerosis (or arteriosclerotic vascular disease) is a condition where the arteries become narrowed and hardened due to an excessive buildup of plaque around the artery wall. The disease disrupts the flow of blood around the body, posing serious cardiovascular complications. Symptoms of atherosclerosis are chest pain (angina); pain in the leg, arm, and anywhere else that an artery is blocked; shortness of breath;...
-
Product Insights
Metrovacesa – Tiara Residential Complex – Andalusia
Equip yourself with the essential tools needed to make informed and profitable decisions with our Metrovacesa - Tiara Residential Complex - Andalusia report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? ·Unleash the full story: Dive deep into...
-
Company Profile
Neovasc Inc – Company Profile
Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include neovasc reducer, neovasc tiara, and neovasc tissue products. Its neovasc tiara is a novel transcatheter device that is designed for treating mitral valve disease and mitral regurgitation and a condition that is often severe and can lead to heart failure and death. Neovasc reducer is used for treating refractory angina. The company’s reducer procedure uses standard catheter-based techniques. It...
Add to Basket -
Product Insights
Neovasc Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Neovasc Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Neovasc Inc (Neovasc) is a medical device manufacturing company that manufactures, develops, and sells cardiovascular disease products. The company’s products include Neovasc reducer, Neovasc tiara, and Neovasc tissue products. Its Neovasc tiara is a novel transcatheter device that is designed for treating mitral valve disease and mitral regurgitation and a condition that is often severe and can lead to heart...
-
Product Insights
Atherosclerosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Atherosclerosis (or arteriosclerotic vascular disease) may occur with symptoms including chest pain (angina), pain in the leg, arm, and anywhere else that an artery is blocked, shortness of breath, fatigue, confusion (if the blockage affects circulation to the brain) and muscle weakness in the legs from lack of circulation. The Atherosclerosis pipeline drugs market research report outlays comprehensive information on the Atherosclerosis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA)...